(PRWEB) June 18, 2012
The US Drug Watchdog has now launched an aggressive national initiative designed to help women recipients of a transvaginal mesh, who are now severely damaged by this type of product. Supposedly the transvaginal mesh products were designed for women, who were suffering from pelvic organ prolapse, and stress urinary incontinence. According to the US FDA the procedure to install a transvaginal was supposed to be minimally-invasive. The US Drug Watchdog now says, "The FDA is now saying transvaginal mesh failures is causing complications in patients such as erosion and infection. Women who experience transvaginal mesh failure may need to have numerous corrective surgeries, IV therapy, blood transfusions and drainage of hematomas or abscesses." The US Drug Watchdog is offering to help all US women, who are now victim's of the transvaginal mesh disaster get to the best possible attorneys, and the group is promising the attorneys will all be women. For more information victims of the Transvaginal Mesh Disaster are urged to contact the US Drug Watchdog anytime at 866-714-6466, or contact the group via their web site at http://USDrugWatchdog.Com
The US Drug Watchdog is indicating symptoms of a vaginal mesh implants may include:
The US Drug Watchdog says, "One of the biggest problems we have with respect to our failed medical device or recalled drug initiative work is the average US consumer never hears about a drug recall or failures involving medical devices like the Transvaginal Mesh Disaster. If you have a friend, or loved one who is a recipient of a Transvaginal Mesh that has already failed or is showing symptoms of a failure, please have them call us at 866-714-6466. We want to make certain these Transvaginal Mesh Disaster victims get to the best possible attorneys, to ensure they get the best possible compensation for their ordeal, and we will do our absolute best to make certain all of the attorneys are women." http://USDrugWatchdog.Com
U.S. District Court for the Southern District of West Virginia Multidistrict litigation (MDL) consolidates all similar cases into one courtroom and will include the Defendants:
C.R. Bard, Inc., (MDL No. 2187);
American Medical Systems Inc., MDL No. 2325);
Boston Scientific Corp., (MDL No. 2326); and Ethicon, Inc. (MDL No. 2327)
Read the full story at http://www.prweb.com/releases/2012/6/prweb9610992.htm.
Copyright©2012 Vocus, Inc.
All rights reserved